NDC 25021-259 – Nelarabine
Nelarabine 5 mg/mL · Injection, Solution · Intravenous
Product NDC25021-259
Product details
- Brand name
- Nelarabine
- Generic name
- Nelarabine
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA212605
- Marketed since
- August 1, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Nelarabine 5 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 25021-259-50 | 1 VIAL in 1 CARTON (25021-259-50) / 50 mL in 1 VIAL | Aug 1, 2024 |
| 25021-259-51 | 6 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL | Aug 1, 2024 |
Other Nelarabine products
- 62332-813 Nelarabine 5 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 46708-813 Nelarabine 5 mg/mL · Injection · Alembic Pharmaceuticals Limited
- 70121-1743 Nelarabine 5 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 43598-142 Nelarabine 5 mg/mL · Injection · Dr. Reddy's Laboratories, Inc.
- 68083-233 Nelarabine 5 mg/mL · Injection · Gland Pharma Limited
- 71288-165 Nelarabine 5 mg/mL · Injection · Meitheal Pharmaceuticals Inc
- 72205-154 Nelarabine 5 mg/mL · Injection · Novadoz Pharmaceuticals LLC
- 81927-111 Nelarabine 5 mg/mL · Injection · Shorla Oncology Inc.
- 81927-375 Nelarabine 5 mg/mL · Injection · Shorla Oncology Inc.
- 39822-0650 Nelarabine 5 mg/mL · Injection · XGen Pharmaceuticals DJB, Inc.
- 70771-1685 Nelarabine 5 mg/mL · Injection · Zydus Lifesciences Limited
- 70710-1726 Nelarabine 5 mg/mL · Injection · Zydus Pharmaceuticals USA Inc.